Arfilzomib-lenalidomide-dexamethasone consolidation after upfront autologous stemcell transplantation caused no significant patient-reported shortness of breath: findings fromthe conpet study

Lene Kongsgaard Nielsen*, Sören Möller, Tine Rosenberg, Niels Abildgaard, Jakob Nordberg Nørgaard, Fredrik H. Schjesvold

*Corresponding author for this work

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date13. Jun 2024
Publication statusPublished - 13. Jun 2024
EventEHA 2024 Hybrid Conference - Madrid, Spain
Duration: 13. Jun 202416. Jun 2024

Conference

ConferenceEHA 2024 Hybrid Conference
Country/TerritorySpain
CityMadrid
Period13/06/202416/06/2024

Cite this